- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
45 Under 45: The Judges
Judges for the 2008 45 Under 45
To judge the Emerging Leadership Awards, Pharm Exec called on its Editorial Advisory Board members as well as other trusted sources. A comprehensive listing of those judges is included below:
Jeffrey Aronin, Ovation Pharmaceuticals
David Balekdjian, The Bruckner Group
Stan Bernard, MD, Bernard Associates
Steve Bliss, Innovex
Kevin Butler, Heritage Partners
Gary Cupit, Somnus Therapeutics
Todd Davis, Cowen Healthcare Royalty Partners
Craig Dunkley, Campbell Alliance
Rob Dhoble, DAS Healthcare, Omnicom
Sander Flaum, Flaum Partners
Cliff Kalb, C.Kalb & Associates, LLC
Mike Luby, TargetRx
Wayne Pines, APCO Worldwide
Peter Pitts, Center for Medicines in the Public Interest; Manning, Selvage & Lee
Douglas Plotkin, PA Consulting
Charlene Prounis, Flashpoint Medica
Mason Tenaglia, Amundsen Group
Alex Scott, Eisai
David Snow, AstraZeneca
Catherine Sohn, GlaxoSmithKline
Steve Rauschkolb, The Crisfield Group
Charlotte Sibley, Shire Pharmaceuticals
David Stern, EMD Serono
Bill Trombetta, St. Joseph’s University
Ceci Zak, Roche
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
